证券时报·2025-08-06 00:14Core Viewpoint - The article discusses the performance of the U.S. stock market on August 5, highlighting a decline in major indices while the pharmaceutical sector saw significant gains due to proposed tariffs on imported drugs by President Trump [2][3][6]. Market Performance - On August 5, all three major U.S. stock indices closed lower: the Dow Jones Industrial Average fell by 0.14% to 44,111.74 points, the S&P 500 dropped by 0.49% to 6,299.19 points, and the Nasdaq Composite decreased by 0.65% to 20,916.55 points [3]. - The ISM reported that the U.S. services PMI for July was 50.1, below the expected 51.5 and the previous month's 50.8, indicating near stagnation in service sector growth [3]. Sector Performance - The pharmaceutical sector saw notable gains, with Pfizer rising over 5% and UnitedHealth Group increasing by over 4% following Trump's announcement of potential tariffs on imported drugs [6][7]. - Major technology stocks mostly declined, with Meta and Microsoft both dropping over 1%, while Amazon's stock rose nearly 1% [3]. - Airline stocks collectively increased, with American Airlines up over 3% and Delta Airlines rising by 0.69% [4]. - Semiconductor stocks generally fell, with the Philadelphia Semiconductor Index down 1.12% and notable declines in companies like GlobalFoundries, TSMC, and ARM [4]. Trade Relations - The European Union announced a suspension of planned retaliatory tariffs against the U.S., which were set to take effect on August 7, as both parties work on a trade agreement [9][10].